|
|
Home  CMSC Online For MS Professionals MS News Room CMSC NewNews
|
CMSC NewNews |
|
|
CMSC NewNews
- March 1, 2010
Stanford University halts CCSVI treatments after two serious incidents
Researchers at Stanford University have halted treatments for chronic cerebrospinal venous insufficiency (CCSVI) according February's edition of the journal Annals of Neurology.
- February 24, 2010
NORD Applauds NIH and FDA Joint Initiative
The National Organization for Rare Disorders (NORD) today praised the announcement by two of the nation’s leading health-related federal agencies of a new collaborative effort to accelerate the development of innovative medical treatments and more effectively evaluate new products to make them available to the public.
- February 8, 2010
Can DO MS Remembers its Founder
Can Do Multiple Sclerosis founder Jimmie Heuga passed away peacefully Monday, Feb. 8, 2010. Can Do Multiple Sclerosis's board and staff are deeply saddened. Our condolences go to his family and friends. He continues to be an inspiration to all.
- January 21, 2010
New Information about Oral Medication to Treat MS
There is much to be excited about with recent news published January 20, 2010 in the New England Journal of Medicine (http://content.nejm.org/). You will find three articles which detail results from the Phase 3 studies of Novartis' Fingolimod (FTY720) and EMD Serono's Cladribine and an editorial by Dr. William M. Carroll, MB, BS, MD, FRACP.
- November 18, 2009
American Brain Coalition ALERT: Contact President Obama to Make Biomedical Research a National Priority in FY 2011
Please join with other advocates nationwide to thank President Obama for his historic commitment to science provided by the American Recovery and Reinvestment Act and to urge him to make biomedical research a national priority by providing strong, sustained funding for the National Institutes of Health in FY 2011.
- November 2, 2009
BAMS Bike Team Raises More Than $51,000 for MS Research
NASHVILLE, TENN – Band Against MS, Inc., (BAMS) is proud to announce their bike team raised $51,249 during the 2009 bike season, beating last year’s contribution by more than $26,000. Money raised goes toward furthering the goals of BAMS and the National Multiple Sclerosis Society (NMSS). BAMS, founded by multi-platinum recording artist Clay Walker, created the bike team as an extension of the artist’s charity to participate in rides across the country and to raise awareness of multiple sclerosis (MS).
- November 2, 2009
Leading MS Lifestyle Empowerment Organization Changes Name
Edwards, Colo. – Can Do Multiple Sclerosis is the new name of the nation’s leading provider of lifestyle empowerment programs for people with multiple sclerosis (MS) and their support partners, announced Kim Sharkey, CEO, Can Do MS.
- October 19, 2009
Consortium of Multiple Sclerosis Centers (CMSC) Examines Self-Management in MS
Hackensack, NJ – The Consortium of Multiple Sclerosis Centers (CMSC) released a white paper analyzing patient self-management in Multiple Sclerosis (MS) to develop recommendations for best practices aimed at improving patients’ lives. The white paper was written by a panel chaired by CMSC member Robert T. Fraser, Ph.D., of the University of Washington Rehabilitation Research and Training Center in Seattle, Washington.
- October 1, 2009
U.S. and European Rare Disease Organizations Sign Strategic Alliance
Danbury, CT. ----- The leading advocacy groups for Americans and Europeans with rare diseases—the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS)—have signed a Memorandum of Understanding to join forces on several key strategic initiatives on behalf of rare disease patients and their families.
- September 18, 2009
A Sad Loss for the MS Community
The leadership of the CMSC and IOMSN are saddened by the loss of Dr. Stanley van den Noort. Dr. van den Noort was a leader in the world of MS care and research. He was greatly beloved by his patients, their families, his professional colleagues, and of course, his family. The world of MS mourns his passing but gratefully acknowledges his work and his contributions to MS care and research which will live on in all those who knew him and learned from him.
- August 25, 2009
New Multiple Sclerosis Fellowship Created in the Name of Pioneer Neuroepidemiologist, John F. Kurtzke, MD, FAAN
Hackensack, NJ ― The Consortium of Multiple Sclerosis Centers (CMSC) and the American Academy of Neurology Foundation (AANF) have announced the creation of the John F. Kurtzke, MD, FAAN, Clinician-Scientist Development Three-Year Award, a jointly-sponsored fellowship in multiple sclerosis (MS) research. The award was conceived by CMSC leadership to honor the contributions of Dr. Kurtzke and inspire new MS healthcare professionals to follow in his path. “Dr. Kurtzke has shown a lifelong dedication to MS research,” said June Halper, Executive Director of the CMSC, “which was virtually nonexistent until he developed his scoring model, the Kurtzke Scale in Multiple Sclerosis.” He later elaborated this scale into Expanded Disability Status Scale (EDSS), one of the most commonly-used clinical tools for measuring MS progression.
- May 27, 2009
CMSC Whitaker Prize Supports Vital MS Clinical Research
Houston, TX and Atlanta, GA ― The Foundation of the Consortium of Multiple Sclerosis (MS) Centers (FCMSC) announced Allison S. Drake, MS, as the 2009 recipient of the Whitaker Prize for MS Research, awarded in memory of the late Dr. John Whitaker. Dr. Whitaker was Chair of the Neurology Department of the University of Alabama at Birmingham (UAB), and an exceptional clinical scientist who first developed the Research Track for the Consortium of Multiple Sclerosis Centers’ (CMSC) Annual Meeting in 2001.
- May 27, 2009
Houston Neurologist, Dr. Victor Rivera Receives CMSC Lifetime Achievement Award for his Contributions to the Field of Multiple Sclerosis Research and Treatment
Houston, TX and Atlanta, GA ― The Consortium of MS Centers (CMSC) proudly presented its “Lifetime Achievement Award” to Dr. Victor Rivera, Professor of Neurology and Medical Director of the Maxine Mesinger MS Comprehensive Care Center at Baylor College of Medicine in Houston, Texas, at the recent CMSC Annual Meeting in Atlanta, GA, May 27-30, 2009.
- May 27, 2009
International Experts in MS Care Convene in Atlanta for Annual Meeting
ATLANTA, GA – Stem cell research offers possibilities of restorative therapy—this time for multiple sclerosis, according to Drs. Mark Freedman, Antonio Uccelli, and Harry Atkins, international experts in MS care and research. This was just one of the latest developments in MS research presented at the Consortium of MS Centers (CMSC) 23rd Annual Meeting in Atlanta, Georgia, May 27th through 30th.
- May 27, 2009
MSWorld, Inc. Launches Online Cognitive-Based Memory Video Game on Inaugural World MS Day
NEW YORK — MSWorld, Inc., a global online support community for people living with multiple sclerosis (MS), has launched a mystery-themed, memory-based video game, titled “The Case of the Missing Matches,” in recognition of the first World Multiple Sclerosis (MS) Day. Beginning today, “The Case of the Missing Matches” video game can be accessed at: http://www.msworld.org/html/memory.htm.
- March 20, 2009
NORD Advocacy Alert - Health Insurance Coverage Protection Act Reintroduced
The following advocacy update is being provided to all NORD Member Organizations: On February 13th, 2009, Anna G. Eshoo (D-CA) and Jim Langevin (D-RI), along with Senators Byron Dorgan (D-ND) and Olympia Snow (R-ME), introduced the Health Insurance Coverage Protection Act (H.R. 1085, S 442). The legislation, introduced in both Houses of Congress in 2008, would set a $10 million minimum lifetime cap on health insurance, with future increases based on inflation.
- March 16, 2009
Accelerated Cure Project for Multiple Sclerosis continuing to grow
(Waltham, MA; March 16, 2009) - Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, today announced that they have finalized plans with R. Philip Kinkel, MD, FAAN and the Beth Israel Deaconess Medical Center (BIDMC) in Boston, to begin the collection there of blood and data samples, to continue building the largest openly accessible, multi-disciplinary repository ever assembled for use in Multiple Sclerosis (MS) research.
- February 20, 2009
The Heuga Center for Multiple Sclerosis’ board appoints Kim Sharkey as new CEO
The Heuga Center for Multiple Sclerosis’ Board of Directors appointed Kim Sharkey, previously Interim Chief Executive Officer and Chief Operating Officer, to Chief Executive Officer (CEO). The Heuga Center’s nominating committee, in conjunction with Colorado-based JVA Consulting, conducted a thorough assessment of needs and capabilities to ensure the organization continues to lead the way with nationally-renowned health and wellness programs for people and families living with multiple sclerosis (MS).
- December 3, 2008
NORD Invites You to Become a Rare Disease Day Partner
The National Organization for Rare Disorders (NORD) is coordinating the observance of Rare Disease Day in the United States on February 28, 2009. On that day—and in the weeks leading up to it—we will join with others around the world to conduct a variety of activities to raise awareness of rare diseases and the need for safe, effective treatments.
- November 4, 2008
A Sad Loss for the MS Community
The Board of Governors and the Administrative Office of the CMSC are saddened by the loss of Steven Schwid, MD, of Rochester, New York. Dr. Schwid has been a leading figure in the world of multiple sclerosis as an expert neurologist and MS researcher. He was a moving force for the CMSC in the development of consensus conferences and the establishment of our Research program. Our sincere condolences to his family and colleagues. He will be sorely missed.
- November 3, 2008
A Sad Loss for the MS Community
The Board of Governors and the Administrative Office of the CMSC are saddened by the untimely passing of Phyllis Weisel-Levison on November 3, 2008. Phyllis Weisel-Levison, RN, BSN formerly of the Albert Einstein College of Medicine, MS Center White Plains, NY, and the New York City Chapter of the National MS Society. She was a pioneer in the world of MS nursing and most recently worked in Hospice Nursing in New York City. She was also a founder of IOMSN and served on the Board of Directors for several years. Our condolences to Phyllis' family and colleagues.
- September 2008
Dr. Stephen Kirzinger Appointed to CMSC Leadership Position
Hackensack, NJ - August 2008 - Dr. Stephen Kirzinger, a thought leader in MS care and research, was recently appointed as Vice Chair to the Education Committee of the Consortium of Multiple Sclerosis Centers (CMSC). This committee receives and reviews abstracts for presentation at the annual meeting of the CMSC which is scheduled to take place on May 27-30, 2009 in Atlanta, GA.
- July 8, 2008
Message from Dr. Lael Stone, Editor-in-Chief, IJMSC
I am excited to let you know of several changes that have begun here at the International Journal of MS Care. We are in a time of transition during which our readership will enjoy the benefits of a number of gradual changes to better serve the community of MS clinicians who represent a broad spectrum of specialties and interests as well as experience levels. We expect these changes to continue for the next few years, and welcome input from all of you regarding how we can serve you better in your professional lives caring for MS patients.
- March 19, 2008
A Reminder to CMSC Member Centers and Program Directors
The April 15 deadline is approaching for Foundation of CMSC scholarship applications in two areas: Applications for MS Workforce of the Future annual meeting scholarships and Summer Research Scholarships to fund medical students conducting research projects. Additionally, there are a limited number of annual meeting training scholarships available for Nurse Practitioners and Physician Assistants. Applications will be evaluated and awarded as they are received. Click here for more
- January 15, 2008
CMSC meets with a delegation of Multiple Sclerosis professionals from Rome, Italy
We had the pleasure of welcoming a delegation from the University of Rome "La Sapienza" and "Ospedale Sant' Andrea" in Rome, Italy to CMSC offices.click here for more
- July 30, 2007
Research identifies new genes linked with MS
CHICAGO (Reuters) - After decades of dead ends, scientists have identified two genes that may raise the risk of multiple sclerosis, lending insight into the causes of the debilitating disease.click here for more
- July 26, 2007
The Heuga Center for Multiple Sclerosis honors the Multiple Sclerosis Coalition at The Heuga Center's benefit
he Heuga Center for Multiple Sclerosis will honor the Multiple Sclerosis (MS) Coalition at The Heuga Center's 22nd Annual Autumn Benefit October 23, 2007 at the St. Regis Hotel in New York City. The MS Coalition is an affiliation of independent MS organizations dedicated to the enhancement of the quality of life for those affected by MS.click here for more
- May 8, 2007
A Sad Loss for the MS Community
Leonor Gold, a well-known and very prestigious Argentine neurologist, passed away this past weekend in Buenos Aires.click here for more
- April 18, 2007
Attention MS Nurses
When making your travel arrangements for attending the CMSC Annual Meeting please consider joining two of our premiere corporate sponsors, Biogen Idec and Elan Pharmaceuticals, on Sunday, June 3, for a breakfast program. Breakfast will be from 8:00-10:00 am at the Washington Hilton &Tower. More information on this exciting program will come during the conference. click here for more
- March 27, 2007
A Sad Loss for the MS Community
Our dear friend and nursing colleague, Linda Morgante, passed away on March 26, 2007 after a courageous struggle with cancer. click here for more
- February 23, 2007
MS Awareness Week Action Alert
In cross-collaboration, MS patient organizations and MS activists from around the world have come together during MS Awareness Week 2007 to call on Congress to increase federal funding for multiple sclerosis research. click here for more
- February 23, 2007
Patent Held by Genentech Is Revoked by Government
The Patent and Trademark Office has decided to revoke a fundamental patent held by Genentech, the biotechnology company, that was at the center of a recent Supreme Court decision.d estimates of the numbers of people affected by various neurological disorders including multiple sclerosis. click here for more
- February 22, 2007
New Study in Mice May Help Explain MS Remissions During Pregnancy
Researchers report that significant changes occur in the tissue of brain and spinal cord of pregnant mice that may help to explain why remission occurs in many women with multiple sclerosis during pregnancy. click here for more
- February 5, 2007
National MS Society Raises Concerns that Recent NIH Study Underestimates Number of People with MS in the U.S.
An article released in the January 30, 2007 issue of the journal Neurology reviews previously published estimates of the numbers of people affected by various neurological disorders including multiple sclerosis. click here for more
- December 14, 2006
Internationally Known MS Expert, Professor W. Ian McDonald, Dies
The whole MS community expresses its sadness over the loss of W. Ian McDonald, MB, ChB, PhD, a former advisor who made outstanding research contributions toward understanding multiple sclerosis. Professor McDonald was Emeritus Professor of Clinical Neurology at the Institute of Neurology at University College in London. click here for more
- November 17, 2006
Natalizumab alters T cell ratio in MS patients
Use of natalizumab in patients with multiple sclerosis (MS) alters the ratio of CD4+ to CD8+ T-cells in cerebrospinal fluid (CSF), researchers have shown. click here for more
- October 23, 2006
Schering gets US OK for Betaseron in early stage MS
FRANKFURT (Reuters) - German drugmaker Schering has received approval from U.S. regulators for the use of its Betaseron drug for early stage multiple sclerosis, it said on Monday. click here for more
- October 19, 2006
Methylthioadenosine effective in animal models of multiple sclerosis
Methylthioadenosine (MTA), an adenine nucleoside produced from S-adenosylmethionine, is effective in animal models of acute and chronic multiple sclerosis (MS), according to a report in the September issue of the Annals of Neurology. click here for more
- October 13, 2006
High-dose cyclophosphamide promising for severe refractory MS
In patients with moderate to severe refractory MS, high-dose cyclophosphamide may lead to disease stabilization and improved functionality and quality of life, according to early results of a study reported in the Archives of Neurology for October. click here for more
- October 6, 2006
Outcomes not necessarily worse with late-onset multiple sclerosis
Late-onset multiple sclerosis (MS) is not always associated with worse outcomes than earlier adult-onset MS, according to a report in the September issue of Neurology. click here for more
- October 4, 2006
Elan and Biogen say Tysabri approved in Canada
Ireland's Elan Corp and U.S. partner Biogen Idec said on Wednesday that Canadian regulators had approved their Tysabri drug as a treatment for relapsing-remitting multiple sclerosis. click here for more
- October 4, 2006
Early treatment of multiple sclerosis yields long-term benefits
Early and ongoing treatment with interferon beta-1a can provide lasting benefits to patients with relapsing-remitting multiple sclerosis (MS), according to a report in the second September issue of Neurology. click here for more
- September 28, 2006
OneNew data confirmed Antibodies to COPAXONE® Do Not Impact its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
New data presented today at the 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Madrid, Spain, showed that antibodies to COPAXONE® (glatiramer acetate injection) developed in all patients with multiple sclerosis (MS) treated with COPAXONE®, but did not interfere with the efficacy of the drug. click here for more click here for more
- September 28, 2006
One-year Data from Phase III Trial Show that New Formulation of REBIF® Offers Substantial Improvement in Tolerability and Immunogenicity Profiles
The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide. click here for more
- September 28, 2006
New data for FTY720 aiming to become the first orally effective multiple sclerosis treatment show sustained benefits over two years
The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide. click here for more
- September 21, 2006
Serono's MS Treatment Gets Fast Track Status
Biotech company Serono said on Thursday its oral cladribine for the treatment of multiple sclerosis has been designated a fast track product by the U.S. Food and Drug Administration. click here for more
- September 14, 2006
FREEDOMS Trial (Fingolimod Research Evaluating Effects of Daily Oral Therapy in MS)
Phase II data showing clinical benefits of novel once-daily oral multiple sclerosis therapy FTY720 (fingolimod) published in New England Journal of Medicine. click here for more
- September 7, 2006
Medicare Reimbursement will be cut by 5.1% by 2007
If Congress does not act before the end of the year, Medicare reimbursement will be cut 5.1 percent in 2007. The time for Congress to prevent cuts to physician reimbursement is now! click here for more
- September 5, 2006
Cannabis-derived MS Treatment Filed in Europe
Sativex, the cannabis-derived product developed by GW Pharmaceuticals could be finally set for approval after a delay of around two years...click here for more
- March 8, 2006
SSDI Delays Query
It has become apparent in some states that delays in the time to decision for SSDI applications and appeals, in general, and for persons with MS in particular, have become significantly longer than previously....click here for more
- March 7, 2006
Medicare Suspends Cap On Rehabilitation Services For Beneficiaries With MS
On January 1, 2006, Medicare beneficiaries became subject to a $1,740 cap on outpatient PT and speech language pathology services and a separate $1,740 per beneficiary limit on occupational therapy....click here for more
- January 29, 2006
March is MS Foundation's MS Education and Awareness Month
March has been designated National MS Education & Awareness Month by the Multiple Sclerosis Foundation (MSF). The primary goals of this month are to increase awareness about MS and to educate and empower those affected by the disease...click here for more
|
|
|
Last Updated ( Thursday, 04 March 2010 )
|
|
